Affiner votre recherche
Résultats 1-10 de 11
Moment analysis of multibreath nitrogen washout in healthy female goats and calves.
1988
Kiorpes A.L. | Clayton M.K.
Campylobacter jejuni infections in gnotobiotic pigs.
1988
Boosinger T.R. | Powe T.A.
Pathogenicity, hemagglutinability and the effect of physicochemical agents on virus of rabbit hemorrhagic disease.
1990
Yoon I.J. | Jeon Y.S.
Enzyme-linked immunosorbent assay (ELISA) as a diagnostic tool for Guatemalan onchocerciasis using a bovine filaria (Onchocerca gutturosa) antigen and blood samples collected on filter paper
1983
Ito, M. | Lujan-T, A. (Servicio Nacional de la Erradicacion de la Malaria, Ministerio de Salud Publica (Guatemala)) | Fukumoto, S. | Kamiya, M.
Characterization and epitope mapping of monoclonal antibodies to the nucleocapsid protein of severe acute respiratory syndrome coronavirus
2008
Kariwa, H.(Hokkaido Univ., Sapporo (Japan)) | Noda, H. | Nakauchi, M. | Ishizuka, M. | Hashiguchi, K. | Hashimoto, S. | Yoshii, K. | Asano, A. | Agui, T. | Kogaki, H. | Kurano, Y. | Uchida, Y. | Fujii, N. | Okada, M. | Takashima, I.
The sudden emergence of severe acute respiratory syndrome (SARS) at the end of 2002 resulted in 774 reported deaths from more than 8000 cases worldwide. As no effective vaccines or antiviral agents are available, the most effective measure to prevent the expansion of a SARS epidemic is the rapid diagnosis and isolation of SARS patients. To establish specific diagnostic methods, we generated nine clones of monoclonal antibodies to nucleocapsid protein (NP) of SARS-coronavirus (SARS-CoV). On immunofluorescent antibody assay and Western blotting analysis, none of the monoclonal antibodies showed cross-reactivity to authentic and recombinant NPs of human coronavirus (HCoV) 229E strain. To determine the region on the NP molecule where the monoclonal antibodies bind, we generated four truncated recombinant NPs and analyzed the reactivity between monoclonal antibodies and truncated NPs. Two monoclonal antibodies reacted with a truncated NP covering from amino acid residues 111 to 230, and seven reacted with another truncated NP covering from amino acid residues 221 to 340. Epitope mapping analysis indicated that monoclonal antibody SN5-25 recognized the amino acid sequence Qsup(245)TVTKKsup(250) on SARS-NP. Within the epitope, Q245, T246, V247, K249, and K250 appeared to form an essential motif for monoclonal antibody SN5-25 to bind. The information about binding sites and epitopes of monoclonal antibodies may be useful for the development of new diagnostic methods for SARS and for analyzing the function of N protein of SARS-CoV.
Afficher plus [+] Moins [-]Genetic and antigenic analyses of a Puumala virus isolate as a potential vaccine strain
2008
Daud, N.H.A.(Hokkaido Univ., Sapporo (Japan)) | Kariwa, H. | Tkachenko, E. | Dzagurnova. T. | Medvedkina, O. | Tkachenko, P. | Ishizuka, M. | Seto, T. | Miyashita, D. | Sanada, T. | Nakauchi, M. | Yoshii, K. | Maeda, A. | Yoshimatsu, K. | Arikawa, J. | Takashima, I.
Puumala virus (PUUV), a causative agent of hemorrhagic fever with renal syndrome (HFRS), is prevalent in Europe and European Russia. No vaccine has been developed for PUUV-associated HFRS, primarily because of the low viral yield in cultured cells. A PUUV strain known as DTK/Ufa-97 was isolated in Russia and adapted for growth in Vero E6 cells maintained in serum-free medium. The DTK/Ufa-97 strain produced a higher viral titer in serum-free medium, suggesting that it may prove useful in the development of an HFRS vaccine. When PUUV-infected Vero E6 cells were grown in serum-free medium, the DTK/Ufa-97 strain yielded more copies of intracellular viral RNA and a higher viral titer in the culture fluid than did the Sotkamo strain. Phylogenetic analysis revealed that PUUVs can be classified into multiple lineages according to geographical origin, and that the DTK/Ufa-97 strain is a member of the Bashkiria-Saratov lineage. The deduced amino acid sequences of the small, medium, and large segments of the DTK/Ufa-97 strain were 99.2% to 100%, 99.3% to 99.8%, and 99.8% identical, respectively, to those of the Bashkirian PUUV strains and 96.9%, 92.6%, and 97.4% identical, respectively, to those of the Sotkamo strain, indicating that the PUUVs are genetically diverse. However, DTK/Ufa-97 and other strains of PUUV exhibited similar patterns of binding to a panel of monoclonal antibodies against Hantaan virus. In addition, diluted antisera (i.e., ranging from 1:160 to 1:640) specific to three strains of PUUV neutralized both homologous and heterologous viruses. These results suggest that the DTK/Ufa-97 strain is capable of extensive growth and is antigenically similar to genetically distant strains of PUUV.
Afficher plus [+] Moins [-]Downregulation of male-specific cytochrome P450 by profenofos
2008
Moustafa, G.G.(Hokkaido Univ., Sapporo (Japan)) | Ibrahim, Z.S. | Ahmed, M.M. | Ghoneim, M.H. | Sakamoto, K.Q. | Ishizuka, M. | Fujita, S.
The health hazards of individual organophosphorus insecticides have been characterized by their acute toxicity, mainly by investigating their cholinesterase inhibition. However, the chronic effects of most of these toxicants on the drug-metabolizing enzymes have not been investigated. Profenofos (O-4-bromo-2-chlorophenyl O-ethyl S-propyl phosphorothioate) is an organophosphorus pesticide widely used in cotton cultivation. In the present study, we investigated the effect of profenofos on male-specific cytochrome P450 (CYP) enzymes in adult Wistar rats. We orally administered 17.8 mg/kg body weight, twice weekly for 65 days. Profenofos downregulated levels of hepatic and testicular CYP2C11 and CYP3A2 mRNA and protein expression. Testicular aromatase (CYP19A) mRNA was decreased in the profenofos-treated rats compared to controls. Overall, the present study suggests that profenofos acts as an endocrine disruptor of male-specific CYP enzymes and affects testosterone concentration, which implicates its deleterious effects on animal or human males chronically exposed to organophosphorus pesticide.
Afficher plus [+] Moins [-]Ecology and epidemiology of anthrax in cattle and humans in Zambia
2006
Siamudaala, V.M.(Zambia Wildlife Authority, Chilanga) | Bwalya, J.M. | Munag'andu, H.M. | Sinyangwe, P.G. | Banda, F. | Mweene, A.S. | Takada, A. | Kida, H.
Anthrax is endemic in Western and North-western Provinces of Zambia. The disease occurs throughout the year and impacts negatively on the economy of the livestock industry and public health in Zambia. During 1989-1995, there were 1,626 suspected cases of anthrax in cattle in Western province and of these 51 were confirmed. There were 220 cases of human anthrax cases in 1990 alone and 248 cases during 1991-1998 with 19.1% and 7.7% case fatality rates, respectively. Interplay of the ecology of affected areas and anthropogenic factors seem to trigger anthrax epidemics. Anthrax has drawn considerable attention in recent years due to its potential use as a biological weapon. In this paper, the history, current status and approaches towards the control of the disease in Zambia are discussed. Quarantine measures restrict trade of livestock and exchange of animals for draught power resulting in poor food security at household levels. Challenges of anthrax control are complex and comprise of socio-political, economical, environmental and cultural factors. Inadequate funding, lack of innovative disease control strategies and lack of cooperation from stakeholders are the major constraints to the control of the disease.
Afficher plus [+] Moins [-]Osmotic fragility of erythrocyte in cattle, sheep and goats
1990
Min, B.M. | Lee, B.W. (Chonnam National University, Kwangju (Korea Republic). College of Agriculture)
The cytokinesis-block micronucleus assay as a biological dosimeter in irradiated lymphocyte : comparison of the response of mouse and human
1993
Kim, S.H. | Kim, T.H. | Rue, S.Y. | Koh, J.H. (Korea Cancer Center Hospital, Seoul (Korea Republic). Laboratory of Radiation Medicine) | Cho, C.K. | Koh, K.H. | Yoon, H.K. (Korea Cancer Center Hospital, Seoul (Korea Republic). Department of Therapeutic Radiology) | Choi, S.Y. (Korea Cancer Center Hospital, Seoul (Korea Republic). Laboratory of Epidemiology)